Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Troytex,
I know the research is very needed.
Last year my wife passed from Alzeihmers and Dementia.
Obviously this type of research is followed by millions for a medicine.
I am not surprised for the rise in price. But in pennyland, these cycles of a fast rise is always brief because many are experienced and aware that it will be brief hence they take profits.
Well, it all depends how serious the research happens to be and what the goals and motivation of the company. Most listed in pennyland are questionable operations.
I do not know much about them either. It appears you know them over the years. I must ask you as you seem to have more knowledge about them and you already have a plan.
Cheers & GLTY
Igc jump in price…real or not.?
Wow..big jump for one day…looking back 3 or 4 years igc has spikes for few days after news media releases and then prices drifts down…I hope to buy a couple hundred shares at $1.80 or $1.95… since I am small investor I am happy to makes couple hundred $ on short term jumps…however if their potential is only 50% realized I guess they can hit 10 $ a share in a year…I research them 4 or 5 years ag..the owners then had bad history of fraud, pump and dump patterns..BUT…with fda clinical trials from university of Florida and us govt this patents…I am willing to take a chance..with beverages, Alzheimer,skin, fibromyalgia patents..I must recognize that they have turned the corner..I hope..Troytex,investor in cannabis and cbd companies for past 6 years
That's the way it goes. It's normal in this business.
Though the research must go on as it's a real need.
GLTY
IGC short lived run for such good news on Alzheimers...
GLTA
Moving in PM on patent news...
https://finance.yahoo.com/news/igc-announces-issuance-patent-treatment-110000295.html
* * $IGC Video Chart 06-07-2021 * *
Link to Video - click here to watch the technical chart video
You really know how to pick winners
Wow good comeback, what are you six?
And you suck at everything else including trading. Proof is right here with you bashing a great company!! And even if it was 2 years old still proves my point as to how stupid you are lmao
You're not the smartest guy around, you replied to a post over two years old. That's why you suck at trading.
Lmao!!! This POS will never see those prices lol. Week almost over and where are they!!
Then again they need to finance some big things...or are they just ripping off investors? Anyway it seemed to me they want to build a skyscraper in India I guess if you buy and hold they may just let you stay in it..I might try but if it gets low again I think. It does look like the OS has tightened up I guess; I don't know probably not from my experience they probably converted them to preferred...
* * $IGC Video Chart 02-10-2021 * *
Link to Video - click here to watch the technical chart video
Mover..
. Nice after hrs buys
.. cool
Double bottom in at 330est?...we shall see ...
Guyz this is the real deal... good company betting on pot alzheimers thing.. no worried..
100% India Scam! These Dot Heads Are Laughing At Stupid U.S Investors...
$IGC perfect recycled news for a recycled company.
SCAM.
Recycled news. This has already wed settled December 21, 2020. See this sec link. https://www.sec.gov/enforce/33-10908-s
$IGC looks like the SEC finally had enough of this scam goodbye.
SEC takes enforcement action against IGC for claims made about cannabis-based treatment for Alzheimer’s symptoms
https://www.marketwatch.com/story/sec-takes-enforcement-action-against-igc-for-claims-made-about-cannabis-based-treatment-for-alzheimers-symptoms-11610392390?mod=flipboard_industries
lol. this is headed back under a dollar.. they have nothing else they can scam announce until June.... 6 months of selling crushes this scam from India.
they will cure biden's alzheimers. fact!
Its all bs.. these guys have and sell other shares every day in different ways.. they report these to stay out of trouble. This is a India stock scam penny stock. Not saying they wont have another pump and dump but they do not have the cure for any disease with there bs cbd snake oil.
What do the codes mean next to the number of shares sold?
Do all directors have to disclose selling shares or only when they drop below or go above 5 percent?
Also, is there a way to figure out if the shares being sold are dilutive or owned?
Not invested here but have watched the warrants for at least five years as I believe cbd could be the most effective option against Alzheimer's and/or dementia. Thanks in advance!
ARE YOU KIDDING? YOUR INVESTING AND YOU DONT READ THE FILINGS..
THEY ARE DUMPING MILLIONS OF DOLLARS WORTH OF SHARES.. TAKING ADVANTAGE OF THE BS MJ PUMP ON THIS DUMB VOTE.
READ THE LAST 3 FORM 4'S.. ALL INSIDERS SELLING.
IF THEY TOOK ADVANTAGE OF THE SPIKE THEY ARE TELLING YOU ITS A GIFT AND SELL ALL YOU CAN... WHILE ALL THE SHEEP AND PUMPERS BY THE SHARES THEY ARE SELLING..
BUT IM THE BAD GUY..LOL
INDIA STOCK SCAM 101
How do you know insiders are selling??
lol.. why are the insiders selling all their shares..?
its because of this fake MJ run up they have to take advantage of it... no matter what!! That's why. India stock scam play
Must be Chicken Soup !
* * $IGC Video Chart 12-02-2020 * *
Link to Video - click here to watch the technical chart video
IGC will be fine, phase 1 trial started. More in the pipeline, weed bill passes this week will go up just on that!!
$IGC
SOMETHING IS COOKING HERE : 11,000 DEC 2 CALLS !!
LOL.. YOU PAY ATTENTION.. IF IT WAS NOT FOR THIS BS MJ RALLY .. THIS POS WOULD BE UNDER A BUCK. EVEN WITH IT... BY THE TIME THE BS TRIAL IS OVER IN JUNE THIS WILL BE UNDER .50. WATCH AND LEARN.. STOP CHEERING THESE CRIMINALS ON.
consolidation pay attention
THINK OF ALL THE PEOPLE YOU SCREWED THIS TIME.. NOW ALL THESE NEWBS STUCK OVER 2.00 .. THIS POS JUST TOOK ADVANTAGE OF THE MJ BS RUN UP.. AND YOU HELPED THESE INDIA CO&*^%$*ERS SCREW THEM..
BUT IM SURE YOUR A PRO AND YOU SOLD RIGHT? LOL LOSER
* * $IGC Video Chart 11-30-2020 * *
Link to Video - click here to watch the technical chart video
$IGC most know this is a scam that makes nothing and bid it up anyways lol the herd mentality
I am glad I didn't mislead anyone IGC WOOHOOOOOOOOOOOOOOO LMFAO
WOO HOO..
THERE IS NOTHING THAT WILL HOLD THIS PRICE UP UNTIL JUNE OF 2021 WHEN THEY GIVE SCAM RESULTS FROM PHASE 1.. IF BAD IT GOES TO SUB PENNY..
THIS WILL TRADE BETWEEN .30 - .50 BY THE TIME JUNE 2021 ROLLS AROUND.
UNLESS THEY ANNOUNCE A COVAD VACINE.. LOL
ALL OTHER MJ STOCKS UP DOLLARS..ACB TLRY CGC
EVEN LITTLE COMPLETE SCAM SNDL UP .28%
IGC DOWN .4% WHY? GREED FROM INDIA
Whatever $$$$$ IGC WOO WOO
YES YOU ARE.. 7.5 MILLION SHARES .. DOWN A PENNY ON A HUGE MJ DAY..
THEY HAVE BOGUS PRE MARKET RUN TO 1.98 TO TRICK EVERYONE AND SELL ALL DAY ALL DAY ALL DAY..
STOP STEALING MONEY FROM PEOPLE .. THIS IS A INDIA SCAM LIKE ALL THE OTHERS
See I'm not misleading people lol IGC$
lmfaohahaha I will lead them to the POT OF GOLD
News looks good
Followers
|
184
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9219
|
Created
|
07/17/09
|
Type
|
Free
|
Moderators |
– IGC Pharma to Discuss AI Partnership and Initiatives at Biotech Showcase 2024 –
POTOMAC, MD., December 19, 2023 / IGC Pharma, Inc. (“IGC Pharma” or the “Company”) (NYSE American: IGC), a clinical-stage pharmaceutical company, announced today that Divisional Direction of Patents, Mexico, has issued a Granting Office Action (GOA) for its treatment of Alzheimer’s disease titled “Method and Composition for Treating CNS Disorder.” The Company is optimistic that the success witnessed in Mexico can pave the way for additional approvals in the U.S. and Europe.
IGC Pharma is currently progressing a Phase 2 trial investigating IGC-AD1 as a treatment for agitation in Alzheimer’s disease, the most common form of a central nervous system disorder (CNS). IGC-AD1, the Company’s lead therapeutic candidate, is a partial CB1 receptor agonist designed with anti-neuroinflammatory properties to address the underlying neurodegeneration resulting in neuropsychiatric symptoms. IGC Pharma has strategically sought patent protection for the IGC-AD1 formulation in many jurisdictions including the U.S., Europe, Canada, and Mexico. Today’s announcement of the issuance of the patent for the drug formulation that targets Central Nervous System (CNS) Disorders marks an important milestone in helping set the stage for potential commercialization.
Alzheimer’s disease is a global public health issue affecting an increasing number of individuals as the population ages. According to the Alzheimer’s Association, by 2050, nearly 13 million Americans will be grappling with Alzheimer’s, and related costs are projected to soar to $1 trillion. The burden extends beyond the individual to families, caregivers, and society at large, with approximately 76% of Alzheimer’s patients experiencing neuropsychiatric symptoms such as agitation.
IGC-AD1 is designed to potentially revolutionize the treatment of Alzheimer’s by improving the quality of life of millions of individuals affected by this devastating disease. The current Phase 2 trial, alongside future investigations, aims to validate the effectiveness of IGC-AD1 in managing agitation in Alzheimer’s and relieving caregiver burden.
IGC Pharma is currently pursuing five drug assets targeting the treatment of agitation related to symptoms of Alzheimer’s disease. These assets include IGC-AD1, TGR-63, LMP, IGC-1C, and IGC-M3, all of which are currently in different stages of clinical trials and development.
About IGC Pharma Inc. (dba IGC):
IGC Pharma is pursuing innovative solutions to fight Alzheimer’s disease and related challenges. IGC Pharma’s portfolio comprises of five assets, all with a singular mission – to transform the landscape of Alzheimer’s treatment. IGC-AD1 and LMP target neuroinflammation, Aβ plaques, and neurofibrillary tangles. IGC-AD1 is a CB1r partial agonist currently in a Phase 2b clinical trial for agitation in dementia due to Alzheimer’s (clinicaltrials.gov, NCT05543681). TGR-63 targets Aβ plaque to disrupt the progression of Alzheimer’s disease. IGC-M3 targets the inhibition of Aβ plaque aggregation with the potential to create a profound impact on early-stage Alzheimer’s. IGC-1C targets tau and neurofibrillary tangles in a forward-thinking approach to Alzheimer’s therapy. In parallel, IGC Pharma is at the forefront of Generative AI development, with projects including clinical trials, early detection of Alzheimer’s, and drug interactions with cannabinoids.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |